Clinical Trial Update: A Trial to Evaluate the Efficacy and Safety of Formoterol Fumarate 20 Mcg/0.5 mL in the Treatment of Patients With COPD [Phase 3]

View source ↗

Summary

A completed Phase 3 trial evaluating the efficacy and safety of formoterol fumarate 20 mcg/0.5 mL for chronic obstructive pulmonary disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Formoterol Fumarate (20 mcg/0.5 mL) inhalation solution (formoterol fumarate)

Snippet

Sponsor: Dey | Conditions: COPD | Phase 3 | Status: COMPLETED